Patterns of Generic Erosion: An International Chartbook : Market Research Report

Patterns of Generic Erosion: An International Chartbook

Published: Oct. 9, 2007 - 54 Pages

Executive Summary: Strategic Considerations; Stakeholder Implications
Overview
Methodology
Overarching Trends in Generic Erosion
United States: Overview; Country-Specifi c Factors Infl uencing Generic Erosion
France: Overview; Country-Specifi c Factors Infl uencing Generic Erosion
Germany: Overview; Country-Specifi c Factors Infl uencing Generic Erosion
Italy: Overview; Country-Specifi c Factors Infl uencing Generic Erosion
Spain: Overview; Country-Specifi c Factors Infl uencing Generic Erosion
United Kingdom: Overview; Country-Specifi c Factors Infl uencing Generic Erosion
Japan: Overview; Country-Specifi c Factors Infl uencing Generic Erosion
Outlook and Implications for the Pharmaceutical Industry
Tables: 1. Drugs Examined in This Report; 2. Date of First Generic Entry for Products That Have Lost Patent or Exclusivity Protection, 1998-2006; 3. Exchange Rates; 4. United States: Originator Brands’ Share of Total Sales of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 5. United States: Originator Brands’ Share of Total Dispensed Units of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 6. France: Originator Brands’ Share of Total Sales of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 7. France: Originator Brands’ Share of Total Dispensed Units of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 8. France: Ex-Manufacturer Generics Prices of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006, Expressed as a Percentage of U.S. Prices; 9. Germany: Originator Brands’ Share of Total Sales of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 10. Germany: Originator Brands’ Share of Total Dispensed Units of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 11. Germany: Ex-Manufacturer Generics Prices of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006, Expressed as a Percentage of U.S. Prices; 12. Italy: Originator Brands’ Share of Total Sales of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 13. Italy: Originator Brands’ Share of Total Dispensed Units of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 14. Italy: Ex-Manufacturer Generics Prices of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006, Expressed as a Percentage of U.S. Prices; 15. Spain: Originator Brands’ Share of Total Sales of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 16. Spain: Originator Brands’ Share of Total Dispensed Units of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 17. Spain: Ex-Manufacturer Generics Prices of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006, Expressed as a Percentage of U.S. Prices; 18. United Kingdom: Originator Brands’ Share of Total Sales of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 19. United Kingdom: Originator Brands’ Share of Total Dispensed Units of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 20. United Kingdom: Ex-Manufacturer Generics Prices of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006, Expressed as a Percentage of U.S. Prices; 21. Japan: Originator Brands’ Share of Total Sales of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 22. Japan: Originator Brands’ Share of Total Dispensed Units of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006; 23. Japan: Ex-Manufacturer Generics Prices of Compounds That Have Lost Patent or Exclusivity Protection, 2000-2006, Expressed as a Percentage of U.S. Prices
Figures: 1. Average Brand Market Share for Compounds That Have Lost Patent or Exclusivity Protection Across the Major Markets; 2. Average Unit-Volume Share for Compounds That Have Lost Patent or Exclusivity Protection Across the Major Markets; 3. United States: Average Brand Market and Unit-Volume Share for Products That Have Lost Patent and Exclusivity Protection; 4. United States: Average Price of Brands and Generics as a Percentage of Respective Brands’ Price Prior to Generic Entry; 5. United States: Correlation Between Generic Price Erosion and Competitive Intensity; 6. France: Average Brand Market and Unit-Volume Share for Products That Have Lost Patent and Exclusivity Protection; 7. France: Average Price of Brands and Generics as a Percentage of Respective Brands’ Price Prior to Generic Entry; 8. France: Correlation Between Generic Price Erosion and Competitive Intensity; 9. Germany: Average Brand Market and Unit-Volume Share for Products That Have Lost Patent and Exclusivity Protection; 10. Germany: Average Price of Brands and Generics as a Percentage of Respective Brands’ Price Prior to Generic Entry; 11. Germany: Correlation Between Generic Price Erosion and Competitive Intensity; 12. Italy: Average Brand Market and Unit-Volume Share for Products That Have Lost Patent and Exclusivity Protection; 13. Italy: Average Price of Brands and Generics as a Percentage of Respective Brands’ Price Prior to Generic Entry; 14. Italy: Correlation Between Generic Price Erosion and Competitive Intensity; 15. Spain: Average Brand Market and Unit-Volume Share for Products That Have Lost Patent and Exclusivity Protection; 16. Spain: Average Price of Brands and Generics as a Percentage of Respective Brands’ Price Prior to Generic Entry; 17. Spain: Correlation Between Generic Price Erosion and Competitive Intensity; 18. United Kingdom: Average Brand Market and Unit-Volume Share for Products That Have Lost Patent and Exclusivity Protection; 19. United Kingdom: Average Price of Brands and Generics as a Percentage of Respective Brands’ Price Prior to Generic Entry; 20. United Kingdom: Correlation Between Generic Price Erosion and Competitive Intensity; 21. Japan: Average Brand Market and Unit-Volume Share for Products That Have Lost Patent and Exclusivity Protection; 22. Japan: Average Price of Brands and Generics as a Percentage of Respective Brands’ Price Prior to Generic Entry; 23. Japan: Correlation Between Generic Price Erosion and Competitive Intensity

Abstract

Generic erosion is accelerating in most markets. Reference pricing, price cuts, and price freezes are now used routinely in major international pharmaceutical markets, including the United States, Europe, and Japan. An increased reliance on prescribing and dispensing generics is certain to continue. In Decision Resources’ first analysis of international ex-manufacturer generic erosion trends over an extended time frame, 23 tables and 23 figures quantify market share and unit-volume erosion patterns of nearly two dozen branded products facing generics competition in seven major international pharmaceutical markets. Armed with data showing the evolution of branded and generic prices over time and the correlation of the intensity of generics competition with generic erosion, pharmaceutical companies may glean strategies for extending the life of crucial products, while generic drug manufacturers can discern ways to capitalize on commercial opportunities.

Get the Answers You Need to Shape Your Strategy

Governmental and private payers in the international markets continue to emphasize cost-containment— • seemingly a boon for generics manufacturers. Under what scenario might the generics boon lead to disappointing profi ts?
Although generic erosion is particularly pronounced in the United States, branded products in the United • States often retain some degree of sales share despite precipitous drops in units dispensed following generics entry. How are branded products in the United States able to retain sales share in the face of high levels of generics prescribing?
Historically, the French generics market was underdeveloped; however, the French government in recent years • has begun a vigorous promotion of generics. Has this vigorous promotion of generics led to signifi cant savings in France?
The U.K. generics market is the second largest in the Europe—only surpassed by Germany. • How much infl uence does the National Health Service have over the prescription and dispensing of generics by physicians and pharmacists?
The Japanese government aims to greatly increase the prescription volume share signifi cantly by • 2012. What substantial obstacles stand in the way of achieving this goal?

Scope

Overarching trends in generic erosion: • infl uences on patterns of generic erosion; international variances in generics usage; erosion patterns in the United States versus Europe and Japan.
United States: • the pronounced challenge of generic erosion; cost-containment measures used by managed care organizations; pharmacy benefi t managers; generics use by Medicare benefi ciaries.
France: • overall erosion trends; the changing governmental promotion of generics prescribing; aggressive targets for generics dispensing in 2007.
Germany: • aggressive erosion patterns; reference-pricing; price cuts for older drugs; the waiver of copayments for certain drugs; growth in the Italian generics markets.
Italy: • the underdeveloped generics market; the trend toward conservative generic price erosion; governmental actions to boost the generics market.
Spain: • gradual, steady erosion; reference pricing; the health care reforms of March 2007; growing demand for generics.
United Kingdom: • overall erosion patterns; roles of the National Health Service, physicians, and pharmacists in infl uencing the use of generics.
Japan: • the scarcity of erosion; government action to assist generics manufacturers; biennial price cuts.
Outlook: • the certainty of generics; various infl uences on generics use in different markets; brand and generics manufactures’ defense strategies.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Patterns of Generic Erosion: An International Chartbook

Table of Contents

Abstract